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ABSTRACT
Objectives: This article reports the psychometric properties
of two new condition-speciﬁc questionnaires: 1) the 18-item
Underactive Thyroid-Dependent Quality of Life Question-
naire (ThyDQoL) individualized measure of perceived
impact of hypothyroidism on quality of life (QoL); and 2)
the 15-item Underactive Thyroid Symptom Rating Ques-
tionnaire (ThySRQ), in which patients rate symptom
bother.
Methods: A cross-sectional survey was conducted of 110
adults with overt and subclinical hypothyroidism, 103
treated with thyroxine. Patients, the majority of whom
(81%) were women, were recruited from primary care (57%)
and from hospital clinics (43%). The mean age of patients
was 55.1 (SD 14.3) years. Respondents rated personally
applicable ThyDQoL life domains for importance and impact
of hypothyroidism, and ThySRQ symptom bother.
Results: Completion rates were high (>98%). All 18
ThyDQoL domains were rated as negatively impacted by
hypothyroidism and important for QoL. The ThyDQoL
had high internal consistency reliability (Cronbach’s
alpha = 0.949 [N = 97]), factor analysis indicated that appli-
cable domains could be combined into an overall Average
Weighted Impact score, for which the sample mean, -3.11
(2.2), showed considerable negative impact of hypothyroid-
ism on QoL (maximum possible range -9 to +3). There
is good preliminary evidence to justify shortening the
ThyDQoL to 14 domain-speciﬁc items. For the ThySRQ
Cronbach’s alpha was 0.808 (N = 95). Highest symptom
bother ratings were for hair problems, weight gain, depres-
sion, cold, and tiredness.
Conclusions: Both the ThyDQoL and ThySRQ are highly
acceptable to patients with hypothyroidism and have good
internal consistency reliability. Their sensitivity to change
now needs to be evaluated in clinical trials.
Keywords: hypothyroidism, quality of life, questionnaire,
symptoms, validation.
Introduction
Hypothyroidism (whereby the thyroid gland produces
insufﬁcient thyroid hormone) is a lifelong chronic con-
dition particularly prevalent in women and the elderly
[1]. A recent large US survey found that 9.5% of the
population had elevated serum levels (>5.1 mIU/l) of
thyroid stimulating hormone (TSH), indicative of
hypothyroidism (both clinical and subclinical) [2]. The
disorder slows the metabolism, with classic symptoms
of slowness of movement, tiredness, low energy,
change in appearance and voice, weight gain, cold
intolerance, poor libido, and constipation. Neuromus-
cular symptoms such as muscle stiffness, cramps, and
easy fatigability are common. There may be cognitive
problems including poor memory, attention deﬁcits,
difﬁculties with calculations, and slow reaction times.
Hypothyroidism is also associated with high psychiat-
ric morbidity, in particular depression and paranoid
disorder [3].
The multiple aversive symptoms of hypothyroidism,
both physiological and psychological, can have a con-
siderable effect on quality of life (QoL). There is cur-
rently controversy about appropriate levels of thyroid
hormone replacement, and greater understanding is
needed for the reasons why some patients feel far from
well on thyroid hormone replacement dosage that
meets current guidelines [4]. Nevertheless, psychosocial
aspects have hitherto received less attention than clini-
cal aspects [5], and multidimensional assessments of
patient-reported outcomes are now needed for clinical
trials and routine clinical use with individual hypothy-
roid patients. A new condition-speciﬁc, individualized
questionnaire, the Underactive Thyroid-Dependent
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Quality of Life Questionnaire (ThyDQoL), has recently
been designed [6] to measure the impact of hypothy-
roidism on different aspects of life. The present article
concerns the evaluation of this questionnaire’s psycho-
metric properties.
We also introduce a new self-completion measure
of symptoms in hypothyroidism, the Underactive
Thyroid Symptom Rating Questionnaire (ThySRQ),
which assesses the degree to which patients are both-
ered by applicable symptoms. The ThySRQ was
designed simultaneously with the ThyDQoL in inter-
views with patients [6], but hitherto has not been
reported. There are instruments in place for the diag-
nosis of hypothyroidism on the basis of symptoms
[7,8] but they are for completion by health profession-
als. Other symptom measures exist [9–15], usually
designed speciﬁcally for a clinical trial [12–15], but
which do not appear to have been validated psycho-
metrically, or designed on the basis of interviews with
patients. Although patients were involved in the iden-
tiﬁcation of important symptoms in the development
of the Chronic Thyroid Questionnaire [11], the
measure itself does not appear to have undergone vali-
dation for completion by patients. Measures of
symptom frequency or relative change [12,13,15] are
not tapping how much “bothered” a patient is by a
symptom: a symptom might occur frequently, but not
trouble the patient unduly and vice versa. There is a
need for a short, validated self-completion measure of
the most common hypothyroid symptoms that has
been developed through interviews with patients. The
present article reports the validation of the new
ThySRQ measure of perceived symptom severity and
the evaluation of its psychometric properties.
Methods
In this cross-sectional study, hypothyroid patients
completed the ThyDQoL and ThySRQ instruments.
Forty-seven patients were recruited from the diabetes
and endocrinology clinic at Queen Elizabeth Hospital,
Gateshead, UK (5% of whom were attending the hos-
pital for their primary hypothyroidism, the remainder
for other endocrine conditions including diabetes or
secondary hypothyroidism, and some had developed
hypothyroidism after treatment of hyperthyroidism
and thus they did not have primary hypothyroidism).
Sixty-three of the sample were recruited from three
local primary care practices in which all patients were
approached who ﬁtted the inclusion criteria. The
reasons patients were recruited from primary care as
well as from a hospital setting were that a) people
referred to hospital may have a more severe form of
disease; and b) hypothyroidism is primarily managed
in primary care and the vast majority of patients are
seen there. Thus, combining the two would give a
sample that included a substantial number of patients
representative of those treated in primary care, as well
as ensuring that more severely affected patients were
included. The age range was 18+ years (no upper
limit), and all patients had a diagnosis of hypothyroid-
ism based on two blood tests taken at least 3 months
apart. People known to have mental health problems
likely to render them incapable of understanding and
completing the questionnaires were not included. The
Gateshead Local Research Ethics Committee gave
approval for the research, which was carried out in
compliance with the Helsinki declaration.
The ThyDQoL
Design of the ThyDQoL was based on the Audit
of Diabetes-Dependent Quality of Life (ADDQoL)
[16,17] and subsequent adaptations of the ADDQoL
for people with renal failure [18], macular degenera-
tion [19], and with adult hypopituitarism [20]. The
ADDQoL was inﬂuenced by work on the development
of an interview method of QoL assessment: the Sched-
ule for the Evaluation of Individual Quality of Life
[21]. Such individualized measures assess QoL from
the viewpoint of individual patients themselves rather
than by using externally imposed deﬁnitions of good
or bad QoL. Thus, the ThyDQoL deﬁnes QoL as “how
good or bad you feel your life to be.” The new
ThyDQoL measure was developed following inter-
views with 38 adults with hypothyroidism at three UK
centers and, as the measure and its design are fully
described elsewhere [6], only a brief description is
provided here.
The ﬁrst two items in the questionnaire provide an
overview of the respondent’s QoL. Question I (QI),
Present QoL, asks respondents to rate their present
QoL on a 7-point scale from excellent to extremely
bad. Question II (QII), Thyroid-dependent QoL, asks
them to rate what their QoL would be if they did not
have hypothyroidism, on a 5-point scale, very much
better, much better, a little better, the same, worse,
providing an overview measure of impact of hypothy-
roidism on QoL. There are 18 additional items cover-
ing different domains of life (Table 1), in which
respondents assess the impact of hypothyroidism on
the domain and then rate how important that domain
is to their QoL. The ThyDQoL is also individualized
by giving respondents the opportunity to indicate
whether a particular domain is not applicable (N/A),
e.g., work or family life.
Scoring
The domain impact ratings are scored from -3 to +1
(Fig. 1) (from greatest negative impact to positive
impact of hypothyroidism on QoL), and importance
ratings from 0 to 3 (from not at all important to very
important). A weighted domain impact score is
obtained by multiplying the domain’s impact rating by
the corresponding importance rating. An overall score
286 McMillan et al.
for the questionnaire, the ThyDQoL Average Weighted
Impact score (AWI) is obtained by summing all appli-
cable weighted domain scores, before dividing by
the number of domains applicable to the individual.
Weighted domain scores and the ThyDQoL AWI score
range from -9 to +3 (maximum negative to maximum
positive weighted impact of hypothyroidism on the
individual domain or on the average of all applicable
domains). The overview items are not weighted by
importance ratings, but QII, Thyroid-dependent QoL,
is scored in the same way as the domains, from -3 to
+1. QI, Present QoL, however, is scored +3 to -3 from
excellent to extremely bad, so that a higher score indi-
cates better QoL.
Respondents may also indicate any other ways in
which they perceive hypothyroidism to affect their
QoL in a “free comments” section at the end of the
questionnaire. This allows for the addition of further
Table 1 ThyDQoL item wording and descriptive statistics (maximum N = 108)
No. Item wording (response option) Abbreviation N/A Missing Mean* (SD) Range Median
QI In general my present quality of life is . . . (excellent—extremely
bad)
Present QoL — 0 0.89 (1.02) -2 to 3 1
QII If I did not have underactive thyroid, my quality of life would
be . . . (very much better—worse)
Thyroid-dependent
QoL
— 0 -1.25 (0.99) -3 to 0 -1
If I did not have underactive thyroid, . . .
1 . . . I would enjoy the things I do in my spare time . . . (very much
more—less)
Spare time — 1 -2.49 (2.71) -9 to 0 -2
2† . . . my working life would be . . . (very much better—worse) Working life 54 0 -3.46 (3.30) -9 to 0 -3
3† . . . my holidays would be . . . (very much better—worse) Holidays 18 0 -2.37 (2.63) -9 to 0 -2
4† . . . my family life would be . . . (very much better—worse) Family life 3 2 -2.74 (2.93) -9 to 3 -3
5 . . . my social life would be . . . (very much better—worse) Social life — 2 -2.00 (2.57) -9 to 0 -1
6† . . . my closest personal relationship would be . . . (very much
better—worse)
Relationship 20 0 -2.91 (3.18) -9 to 0 -2
7† . . . my sex life would be . . . (very much better—worse) Sex life 32 1 -2.69 (3.12) -9 to 0 -2
8 . . . physically I could do . . . (very much more—less) Physically do — 3 -3.23 (2.82) -9 to 0 -2
9‡ . . . my energy levels would be . . . (very much higher—lower) Energy — 1 -4.21 (3.11) -9 to 0 -4
10 . . . the speed I could do things would be . . . (very much
faster—slower)
Speed do — 0 -2.78 (2.52) -9 to 0 -2
11 . . . getting out and about (e.g., shopping, short trips) would be . . .
(very much easier—more difﬁcult)
Get out and about — 0 -2.60 (2.90) -9 to 0 -2
12 . . . I could handle my household tasks . . . (very much
better—worse)
Household tasks — 2 -3.37 (2.89) -9 to 0 -3
13 . . . my physical appearance would be . . . (very much
better—worse)
Physical appearance — 0 -3.24 (3.24) -9 to 0 -2
14†‡ . . . my weight would be . . . (very much better—worse) Weight 22 0 -4.51 (2.97) -9 to 0 -4
15†‡ . . . my experience of bodily discomfort would be . . . (very much
less—greater)
Bodily discomfort 19 0 -4.29 (2.81) -9 to 2 -4
16†‡ . . . I would feel depressed or low . . . (very much less—more) Depression 31 1 -4.36 (2.73) -9 to 0 -4
17† . . . my motivation to do things would be . . . (very much
greater—less)
Motivation 13 0 -4.84 (2.79) -9 to 0 -4
18 . . . my feelings about the future (e.g., worries, hopes) would
be . . . (very much better—worse)
Future — 1 -2.87 (2.86) -9 to 0 -2.5
*Mean ThyDQoL score for QI, mean ThyDQoL weighted impact score for QII, and mean ThyDQoL weighted domain impact scores for items 1 to 18.
†Indicates items for which an opening question allows respondents to indicate that the item is not applicable to them and, if so, move on to the next item.
‡Item excluded from calculation of AWI-14. Maximum possible score ranges: QI, Present QoL (+3 to -3), QII,Thyroid-dependent QoL (-3 to +1), 18 domain items (-9 to +3).
AWI,Average Weighted Impact score; N/A, not applicable; QoL, quality of life;ThyDQoL, Underactive Thyroid-Dependent Quality of Life Questionnaire.
ThyDQoL © Prof Clare Bradley: 22.7.03. Standard UK English (rev. 22.7.03).Health Psychology Research,Department of Psychology,Royal Holloway,University of London,Egham,
Surrey,TW20 0EX, UK.
  4 Do you have family/relatives? 
    Yes If yes, complete (a) and (b).
     No If no, go straight to Question 5.
 (a) If I did not have underactive thyroid, my family life would be: 
-3* -2 -1 0 1
very much better much better a little better the same worse
 (b) My family life is: 
3 2 1 0
very important important somewhat important not at all important 
Figure 1 Example of aThyDQoL domain item,
which has a not applicable response option.
*Scores are not shown on the ThyDQoL ques-
tionnaire. ThyDQoL, Underactive Thyroid-
Dependent Quality of Life Questionnaire.
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domains to the questionnaire in the future, if required,
as part of its continuing development.
The ThySRQ
When designing the ThyDQoL, a number of symptoms
were initially included in the measure, on the basis of
a review of the literature on hypothyroidism and dis-
cussions with clinicians. However, during the early
stages of the process of conducting interviews with
patients, the majority of these symptoms were found to
be unsuitable for inclusion as ThyDQoL domains,
being too speciﬁc in nature to be important for many
aspects of life, e.g., voice problems, or because some
patients were unsure whether they were attributable to
hypothyroidism. Four symptoms were retained in the
ThyDQoL, however, because patients mentioned them
frequently and spontaneously as being particularly det-
rimental to their QoL: energy levels, weight, bodily
discomfort, and depression. As interviews progressed
it was decided to develop a separate questionnaire, the
ThySRQ, for completion by patients. ThySRQ design
was inﬂuenced by design of the Diabetes Symptom
Checklist [22] and the Asthma Symptoms Question-
naire [23]. Symptoms selected for inclusion were based
on the literature, consultations with endocrinologists,
and were the most frequently mentioned symptoms in
the interviews. The method used to design the ThySRQ
was the same as for the ThyDQoL [6], and the
ThySRQ was ﬁnalized and piloted in semi-structured
interviews with 10 patients conducted at two centers
(London and Surrey): two men and eight women
(mean age 49 [SD 14.3], range 32–67 years), while the
ThyDQoL involved 18 interviews in Gateshead as well
as 20 in London and Surrey.
The ThySRQ has 15 symptoms with a 4-point
symptom bother scale measuring perceived symptom
severity, and is introduced: “This questionnaire asks
you about symptoms that can be associated with
underactive thyroid and that you may have experi-
enced in recent weeks.” Respondents provide a bother
rating for applicable symptoms, indicating how much
the symptom bothers them from not at all, a little,
quite a bit, very much (scoring 0, 1, 2, and 3, respec-
tively). Any patients who report that they do not have
a symptom are given a symptom bother rating of zero
(not at all bothered). See Figure 2 for an example of an
item, and a list of the 15 symptoms. The term “in
recent weeks,” while not speciﬁc, has been found,
during interviews or in questionnaire development
work, to be interpreted as meaning the past 3 to
6 weeks. Although it would be possible to specify a
time period (e.g., the past four weeks), in practice
patients are not able to remember so precisely when
symptoms occur and such speciﬁcity may give an illu-
sion of precision that does not exist.
Statistical Analyses
Normality of distributions was determined through
investigation of histograms and z (skew) scores (com-
paring the skewness value with zero using the z distri-
bution), where z (skew) scores between 2.58 are
indicative of normality [24].
No data from respondents selecting a N/A response
option on the ThyDQoL would normally be included
in factor and reliability analyses. N/A responses are
treated as missing by the statistical package used (SPSS
for Windows, Release 10.0). Furthermore, if the SPPS
default of list-wise deletion of missings is used, all
1(a) Have you felt tired in recent weeks?   Yes No
  (b) If yes, how much does feeling 
tired bother you? not at all a little quite a bit very much 
Have you … (symptom) … in recent weeks?
1. …. felt tired … 
2. …. gained weight … 
3. …. felt colder than other people … 
4. …. had constipation … 
5. …. had hair problems (e.g., hair loss, coarseness) …   
6. …. had skin problems (e.g., dryness, coarseness) … 
7. …. had nail problems (e.g., brittleness, flaking) … 
8. …. had loss of appetite … 
9. …. had hearing problems … 
10. …. had voice problems (e.g., hoarseness, huskiness) … 
11. …. had speech problems (e.g., slowness, inaccuracy) … 
12. …. had memory problems … 
13. …. had problems with your concentration … 
14. …. felt giddy or dizzy … 
15. …. felt depressed or low … 
Figure 2 Example of a ThySRQ item and an
abbreviated form of the 15 symptom questions.
ThySRQ © Prof C Bradley: 22.7.03. Standard UK
English (rev. 22.7.03). Health Psychology
Research, Department of Psychology, Royal
Holloway, University of London, Egham, Surrey,
TW20 0EX, UK. ThySRQ, Underactive Thyroid
Symptom Rating Questionnaire.
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cases that have any missing values across all 18 items
are lost to analysis, so considerable data could be lost.
From 3% to 50% of volunteers selected N/A on items
where the option was available, N/A responses were
therefore coded as zero for factor and reliability analy-
ses, with pair-wise deletion of data missing for other
reasons, as in the original development of the
ADDQoL [16]. Coding a N/A response for a particular
domain as zero implies that the domain has no impact
on QoL. Note that any genuinely missing values (as
opposed to N/A responses) are not substituted for in
this way. The minimum acceptable Cronbach’s alpha
coefﬁcient of internal consistency reliability was taken
as 0.8 [25] and acceptable corrected item-total corre-
lations were >0.2 [26]. To assess the effects of missing
domain data (impact or importance ratings) on the
reliability of the ThyDQoL, reliability analyses were
run sequentially, deleting the strongest item each time
(i.e., deleting the item having the lowest “alpha if item
deleted” and therefore contributing most to the scale’s
internal reliability) [27]. Factor structure was explored
using Principal Components as an extraction method
with Varimax rotation. Loadings greater than 0.3 are,
by convention, considered salient and one of 0.6 is
considered high [28] but salient loadings were here
taken as 0.4 to ensure ﬁndings were robust. Corre-
lations between questionnaire variables were explored
using Pearson’s r and Spearman’s rho for parametric
and nonparametric data, respectively.
Construct validity was not speciﬁcally assessed,
because there were no a priori hypotheses about
strength or direction of correlations or subgroup dif-
ferences in relation to biomedical variables. Subgroup
analyses were nevertheless undertaken and explored
differences in treatment and degree of hypothyroidism
(subclinical vs. overt) using t-tests or Mann–Whitney
tests for parametric and nonparametric data respec-
tively, and differences in TSH level (within the
reference range, above or below this range) using
Univariate Analysis of Variance. Two-tailed signiﬁ-
cance was applied throughout. To reduce type 1 error,
the Holm’s sequential Bonferroni procedure for mul-
tiple tests [29] was applied whereby the number of
multiple tests divides alpha, but the denominator
decreases by one for each signiﬁcant result.
Initial Analyses to Determine Whether the Four
Recruitment Samples Could Be Combined
There is a possibility that subgroup differences associ-
ated with data from the four recruitment sources might
create artifactual correlations in the combined sample,
if the subgroup mean scores differed consistently
across items. This was investigated by converting the
scores to standardized z-scores within each subgroup
before combining the subsets of scores. Such standard-
ization renders group means identical and thereby
removes the possibility of correlations caused by sub-
group differences (a method adopted when developing
the ADDQoL [16]). Forced one-factor solutions on the
raw scores, and then on the z-scores, produced two
sets of factor loadings that were then compared using
correlation and regression analyses. There was no sig-
niﬁcant difference between loadings of standardized
and raw scores: the correlation of 0.998 was close to 1,
the constant was 0.0, and the slope of the regression
line (1.001) did not differ signiﬁcantly from 1,
[t(15) = 60.28, P > 0.05]. Thus, initial analyses dem-
onstrated that the four recruitment groups could be
treated as one sample for reliability and factor analyses
(for which a larger N is desirable).
Results
The Study Sample and Questionnaire Completion Rates
Of the 128 patients invited to complete the ThyDQoL
and ThySRQ, 110 accepted and returned completed
questionnaires (participation rates of 90% and 83% at
the hospital clinic and primary care, respectively). The
characteristics (ethnicity and age) of responders were
similar to nonresponders, but there was a signiﬁcant
sex difference (P = 0.042), because the ratio of nonre-
sponders to responders was 0:21 (men) but 18:89
(women). There were four sources of recruitment: hos-
pital clinic (47 patients), and three primary care prac-
tices, providing 9, 6, and 48 patients, respectively. The
mean age of the sample was 55.1 years, and mean
duration of hypothyroidism was 8.3 years. The ratio
of women to men was 9:2, similar to the sex ratio of
thyroid disease found in the general US population in
a recent study [30]. The great majority of patients had
autoimmune hypothyroidism (N = 98, 89%) of whom
11 patients had subclinical hypothyroidism. The great
majority (N = 103, 94%) were receiving thyroxine
replacement. Measurements of TSH levels were avail-
able for 95 patients (86%) (median 2.4 mu/l), but in
the case of free thyroxine (FT4) only 49 patients (45%)
(mean 17.4 pmol/l). See Table 2.
Health-care professionals prompted patients
recruited at the hospital to complete any missed items,
however, completion rates for the 63 questionnaire sets
collected at the primary care clinics (where patients
were not prompted) were: 1) ThyDQoL: impact
ratings (98.5%), importance ratings (98.1%). The
data from two patients (one from the hospital clinic
and the other from primary care) were excluded from
ThyDQoL psychometric analyses owing to large
numbers of missing responses (half or more of the 18
items missing and large numbers of N/A responses),
providing a sample of 108; and 2) ThySRQ: 99.9%
(parts a and b). The data from all 110 patients were
available for ThySRQ analyses.
ThyDQoL
Domains reported as most severely (and negatively)
impacted by hypothyroidism were: motivation (mean
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weighted impact = -4.84), weight (-4.51), and depres-
sion (-4.36) (maximum possible range -9 to +3)
(Table 1). The majority of respondents (71%) per-
ceived that hypothyroidism had had a negative impact
on overall QoL (mean QII, Thyroid-dependent QoL,
was -1.25), and QI, Present QoL, was rated as
between good and neither good nor bad (mean 0.89)
(Table 1). Transformations of any non-normal distri-
butions left three items with slightly skewed distribu-
tions (z [skew] ranging from 2.8 to 4.0).
The 18-item ThyDQoL had very high internal con-
sistency reliability (Cronbach’s alpha = 0.949, stan-
dardized item alpha = 0.95, N = 97 [N/A responses
coded as zero]). All corrected item-total correlations
were satisfactory (>0.2, range 0.49–0.88), the lowest
being item 16, depression, which also detracted
slightly from overall scale alpha (0.950). An unforced
factor analysis produced two components (after
Varimax rotation) with eigenvalues >1, accounting for
55.4% and 7.3% of the variance. Several items double
loaded and there was no readily interpretable pattern
of factor loadings (Table 3). Forcing the items onto
greater numbers of factors did not clarify the picture
either. The scree plot indicated only one strong factor.
A forced one-factor analysis showed all 18 items
had satisfactory loadings (>0.5) on the single factor
(accounting for 55.4% of the variance) (Table 3), indi-
cating that all applicable domains could be combined
into an overall Average Weighted Impact score (AWI-
18), reﬂecting a maximum of 18 weighted domain
impact scores. The AWI-18 mean score of -3.11 (2.2)
indicated overall negative perceived impact of
hypothyroidism on QoL. Calculation of ThyDQoL
AWI-18 was reliable at alpha = 0.9 with a maximum
of ﬁve items missing and reliable at alpha = 0.8 with a
maximum 10 missing items. It is therefore reasonable
to calculate AWI-18 providing at least half of the items
(i.e., domain-speciﬁc items) have been completed.
The correlation between AWI-18 and QII, Thyroid-
dependent QoL, (r = 0.69, P < 0.001, N = 108), was
sufﬁciently high for QII to replace the full ThyDQoL
for some purposes. There were no a priori hypotheses
regarding any subgroup differences, and the study was
not powered to detect any, and indeed no signiﬁcant
treatment subgroup differences were found. Neverthe-
less, it is interesting to note that the difference in QII,
Thyroid-dependent QoL, between those with overt
and subclinical hypothyroidism approached signiﬁ-
cance (Bonferroni correction required P-value 0.05/
3 = 0.017): those with overt (treated) hypothyroidism
tended toward greater perceived negative impact of
hypothyroidism on QoL, (mean = -1.31 (1.0), N = 98)
than those with subclinical hypothyroidism, (mean =
-0.7 (0.67), N = 10); t(13.4) = -2.57, P = 0.023.
Twenty-two patients responded in the free com-
ments section but when their comments were analyzed,
it was found that they were expanding on their
responses to existing questionnaire domains, or were
referring to aspects of symptoms or treatment covered
in the ThySRQ or the Underactive Thyroid Treatment
Satisfaction Questionnaire [6], respectively. No new
domains were indicated.
ThySRQ
The most common reported symptoms were tiredness
(90% of respondents), feeling depressed or low, and
Table 2 Characteristics of study participants (N = 110)
Mean (SD) Range N
Mean age (years) 55.1 (14.3) 23–84 110
Mean duration of hypothyroidism (years) 8.3 (8.9) 0.2–57 103
Age at leaving full-time education (years) 16.4 (2.8) 14–27 94
BMI (kg/m2) 28.6 (6.4) 18–48.8 99
TSH (mu/l) 3.9 (5.0) 0.02–28.7 95
FT4 (pmol/l) 17.4 (4.4) 8.9–28.4 49
N
Ratio women to men 89:21
Ratio white Caucasian to non-white 108:2
Hypothyroidism:
Autoimmune 87
Secondary to treatment for thyroid
cancer or hyperthyroidism
9
Secondary to lithium treatment 1
Secondary to amiodarone treatment 2
Subclinical (autoimmune)* 11
Treatment:
Thyroxine-treated 103
Not receiving thyroxine 7†
*Subclinical hypothyroidism deﬁned as TSH level >4 mu/l and FT4 level in normal
range (9–25 pmol/l) [34].
†All with subclinical hypothyroidism. The following comorbid conditions occurred:
hypertension (26 patients), osteoarthritis (10), ischaemic heart disease (9), asthma (8),
type II diabetes (8), rheumatic disorder (7), hypercholesterolaemia (6), type I diabetes
(6), cancer (4), pregnancy (4), depression (4), Addison’s disease (3), pernicious anaemia
(3), coeliac disease (2).Any other disorders were present in a maximum of one patient
and are not reported. Several patients had multiple comorbid conditions.
BMI, body mass index; FT4, free thyroxine;TSH, thyroid stimulating hormone.
Table 3 ThyDQoL unforced, and forced one-factor analyses*
Unforced Forced
1 2 one-factor
1. Spare time 0.417 0.743 0.814
2. Working life 0.743 0.608
3. Holidays 0.783 0.740
4. Family life 0.546 0.637 0.835
5. Social life 0.794 0.809
6. Relationship 0.690 0.729
7. Sex life 0.690 0.642
8. Physically do 0.640 0.644 0.908
9. Energy 0.678 0.534 0.859
10. Speed do 0.744 0.449 0.849
11. Get out and about 0.636 0.485 0.795
12. Household tasks 0.742 0.762
13. Physical appearance 0.569 0.654
14 Weight 0.753 0.603
15. Bodily discomfort 0.669 0.643
16. Depression 0.445 0.529
17. Motivation 0.756 0.821
18. Future 0.719 0.671
*Principal component extraction with varimax rotation, not applicable responses
coded as zero. Loadings 0.4 are shown.
ThyDQoL, Underactive Thyroid-Dependent Quality of Life Questionnaire.
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skin problems (Table 4). The mean number of symp-
toms reported per patient was 7.4 (3.2), N = 107, with
six patients indicating they had 13 or more symptoms.
Almost one-third reported being very much bothered
by symptoms of tiredness, weight gain or depression
when applicable. The highest mean bother ratings
were for hair, weight gain, depressed, and cold. When
data were examined from the 57 respondents who had
either no comorbidities (N = 42), or whose only
comorbidities were likely to be perceived by patients
as symptomless (hypertension and hypercholestero-
laemia, N = 15), the picture was only a little different:
the most common reported symptoms were tiredness,
depression, problems with concentration and skin,
weight gain, memory, and cold (full results not
reported).
Exploratory psychometric analyses were performed
on the ThySRQ scale formed by the 15 symptom
bother ratings although the questionnaire, being a
number of disparate symptoms, was not expected to
have high internal consistency reliability or any par-
ticular factor structure. ThySRQ internal consistency
reliability was unexpectedly high: Cronbach’s alpha
= 0.808, standardized alpha = 0.81, N = 95, with all
corrected item-total correlations >0.2. Only two items
would increase alpha if deleted from the scale (items 5,
hair and 9, hearing), and by no more than 0.002 (full
results not shown). Results of unforced and forced
factor analyses were unclear, with insufﬁcient evidence
of satisfactory subgroups of symptoms that could
produce reliable subscale scores. Forced one-factor
analyses showed 12/15 items loading >0.44 but con-
stipation, hair and hearing fell short of this (0.35–
0.28) indicating that a total score is not fully justiﬁed.
This result was not unexpected.
Chi-square tests found no signiﬁcant differences
in symptom frequency of thyroxine-treated and
untreated patients nor were signiﬁcant correlations
found between TSH (a tissue marker for severity of
hypothyroidism) and ThySRQ bother ratings, once the
Bonferroni correction had been applied.
Relationships between the ThySRQ and
ThyDQoL Questionnaires
When both ThyDQoL and ThySRQ questionnaires are
administered to patients it would be prudent, if anal-
ysing relationships between ThyDQoL AWI and
ThySRQ symptom bother ratings, to exclude patients’
responses to the four ThyDQoL symptom domains
(energy, weight, bodily discomfort, and depression)
from the calculation of the AWI score, i.e., a maximum
of 14 items should be included in the AWI-14 score.
Analyses showed a very high internal consistency reli-
ability of the 14-item ThyDQoL (Cronbach’s alpha
= 0.944, N = 99), with lowest corrected item-total cor-
relation of 0.57. All loadings on a forced one-factor
analysis were >0.6. This provided evidence for the Ta
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reliability and validity of calculating overall AWI-14.
Mean ThyDQoL AWI-14 for the sample was -2.86
(2.22), slightly less negative than -3.11 (2.2) for the
full 18-item AWI-18, as expected.
When correlating AWI-14 with ThySRQ bother
ratings, the strongest signiﬁcant negative correlations
were found (in decreasing order) with tiredness, con-
centration, depressed, weight gain, cold, speech, and
skin (Table 5), indicating that increased symptom
bother was associated with greater negative impact
of hypothyroidism on QoL. The correlations with
AWI-14 were very similar to those with the full
18-item ThyDQoL AWI-18 (Table 5) indicating that
concerns about spuriously high correlations between
ThySRQ and AWI-18 were not supported. Correla-
tions between symptoms and AWI scores were low to
moderate (range -0.1 to -0.6), an indication that
symptoms and QoL are distinct and separate patient-
reported outcomes. A stepwise multiple regression
analysis was conducted to evaluate how well the
bother ratings for the ﬁve symptoms with the highest
correlations with QI, Present QoL, i.e., tiredness,
depressed, cold, concentration, and giddy (Table 5),
predicted Present QoL. Only tiredness was a signiﬁ-
cant predictor of Present QoL: (F1,98 = 31.1, P <
0.001). The sample multiple correlation coefﬁcient was
0.49, indicating that 24% of variance in QI could be
accounted for by tiredness: the greater the bother
rating for tiredness, the worse the present QoL.
Moderate signiﬁcant negative correlations were
found between the number of applicable symptoms and
ThyDQoL overview items QI, Present QoL (r = -0.42),
and QII, Thyroid-dependent QoL (r = -0.43) (P <
0.001, N = 105) indicating decreased present QoL, and
greater negative impact of hypothyroidism on QoL,
with increasing numbers of symptoms.
Discussion
The ThyDQoL is a new individualized measure of the
perceived impact of hypothyroidism on QoL, with high
completion rates indicating good acceptability to
respondents. Internal consistency reliability was excel-
lent and factor analyses highly supportive of the com-
bination of all 18 weighted domains into a single
average score, the ThyDQoL AWI-18 score, which
indicated moderately severe perceived negative impact
of hypothyroidism on QoL in this sample. Useful infor-
mation can be elicited from the single overview items.
On average, respondents’ present QoL (QI) was per-
ceived to be between good and neither good nor bad
andQII, concerning impact of hypothyroidism onQoL,
could provide an approximate substitute for the full
ThyDQoL for some purposes (e.g., when respondent
burden is of particular concern), because the correlation
between QII and overall ThyDQoL AWI-18 was high
(r = 0.69). Analyzing individual domains separately can
provide rich information. For example, we found that,
despite most patients receiving thyroxine replacement
to normalise TSH levels, hypothyroidism still had a
marked negative impact, particularly on motivation,
weight, feelings of depression, bodily discomfort, and
energy, which may well impact on several other
domains, such as spare-time activities or work. More
than 70% of respondents reported feeling depressed or
having bodily discomfort in recent weeks. Content
validity was supported, because no new ThyDQoL
domains emerged when analysing the free comments
section, and all existing domains detected negative
impact of hypothyroidism,withmeanweighted domain
impact scores of -2 or less, as shown in Table 1.
The new ThySRQ measures both symptom fre-
quency and the degree to which patients are bothered
Table 5 Correlations between ThySRQ and ThyDQoL questionnaires
ThySRQ symptom Correlations with AWI-18 Correlations with AWI-14
Correlations with
QI, Present QoL
1. Tiredness -0.61, P < 0.001* -0.61, P < 0.001* -0.44, P < 0.001*
2. Weight gain -0.47, P < 0.001* -0.43, P < 0.001* -0.15, P = 0.13, n.s.
3. Cold -0.38, P < 0.001* -0.37, P < 0.001* -0.30, P < 0.01
4. Constipation -0.27, P < 0.01 -0.26, P < 0.01 -0.19, P = 0.05
5. Hair -0.21, P = 0.029 -0.22, P = 0.022 -0.11, P = 0.27, n.s.
6. Skin -0.28, P < 0.01 -0.28, P < 0.01 -0.12, P = 0.23, n.s.
7. Nails -0.11, P = 0.263, n.s. -0.11, P = 0.26, n.s. -0.16, P = 0.11, n.s.
8. Appetite -0.17, P = 0.083, n.s. -0.17, P = 0.085, n.s. -0.34, P < 0.001*
9. Hearing -0.11, P = 0.25, n.s. -0.11, P = 0.25, n.s. -0.11, P = 0.28, n.s.
10. Voice -0.26, P < 0.01 -0.27, P < 0.01 -0.04, P = 0.71, n.s.
11. Speech -0.29, P < 0.01 -0.29, P < 0.01 -0.03, P = 0.73, n.s.
12. Memory -0.25, P = 0.011 -0.26, P = 0.008 -0.18, P = 0.07, n.s.
13. Concentration -0.49, P < 0.001* -0.50, P < 0.001* -0.29, P < 0.01
14. Giddy -0.24, P = 0.012 -0.23, P = 0.015 -0.27, P < 0.01
15. Depressed -0.47, P < 0.001* -0.45, P < 0.001* -0.40, P < 0.001*
All correlations are Spearman’s rho and those which would remain signiﬁcant after Bonferroni correction requiring minimum P-value of 0.0033 are marked with asterisks (*).
AWI-18/AWI-14,AverageWeighted Impact score of theThyDQoL questionnaire (18 items or 14 items, respectively); n.s., not signiﬁcant;QoL, quality of life;ThyDQoL,Underactive
Thyroid-Dependent Quality of Life Questionnaire;ThySRQ, Underactive Thyroid Symptom Rating Questionnaire.
N ranged from 103 to 108 respondents.
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by symptoms associated with hypothyroidism. All 15
symptoms were experienced recently by at least some
patients and there was a wide spread of frequencies of
responses from not at all bothered to very much both-
ered. Internal consistency reliability was unexpectedly
high, but factor analysis did not support the calcula-
tion of a total symptom bother score. Analysis of the
most frequently reported symptoms (tiredness, depres-
sion, weight gain, and problems with skin, concentra-
tion, and memory) and bother ratings, conﬁrmed the
typical picture of hypothyroidism: physiological symp-
toms connected with slowing of the metabolism and
also reduced psychological well-being and impaired
cognitive functioning. Although measures of health
status are often and erroneously described as QoL
measures [31,32], in this study symptoms (an aspect of
health status) and QoL were distinct and separate
patient-reported outcomes, as indicated by low to
moderate correlations between symptom bother
ratings and ThyDQoL AWI.
The ThyDQoL includes four symptom items that
are also covered on the ThySRQ symptom measure,
namely energy, weight, bodily discomfort, and depres-
sion. We recommend that these four items be
excluded from the calculation of ThyDQoL AWI
when the questionnaire is administered with the
ThySRQ, to avoid duplication and spurious correla-
tions between the two questionnaires. The equivalent
symptoms on the ThySRQ (tiredness, depressed,
weight gain, and cold) still had some of the strongest
correlations with AWI-14, suggesting that the impact
of those symptoms on QoL is reﬂected in ratings of
many domains, and symptom-speciﬁc domains are
not required in the ThyDQoL, although they are
likely to increase face and content validity where no
symptom measure is used. If troublesome symptoms
can be reduced, QoL of patients may be improved
[33]. The data suggested that patients were most
bothered by hair problems, weight gain, depression,
feeling cold, and tiredness and, of these symptoms,
depression, feeling cold, and tiredness were signiﬁ-
cantly correlated with ratings of present QoL. An
optimal strategy for treating individual patients may
be to identify individual patients’ most bothersome
symptoms using the ThySRQ and the impact of
hypothyroidism on their QoL using the ThyDQoL
and target efforts according to an individual’s needs
and priorities. Nevertheless, to improve the QoL of
their patients in general, the present results suggest
that health-care professionals could most usefully
direct their efforts to alleviating the symptoms of
depression, feeling cold, and tiredness. Symptoms can
be selected for the ThySRQ to suit the purposes of a
particular clinical trial. Further symptoms may need
to be added if required (e.g., side effects of a new drug
under evaluation), although the rationale of any dele-
tions or additions would need to be justiﬁed.
One limitation of the study was that only two
patients were recruited from ethnic minorities,
although the incidence of hypothyroidism is similar in
Whites and Asians but lower in Afro-Caribbeans.
Although the clinical manifestation of hypothyroidism
would be expected to be similar for all ethnic groups,
it is possible that different ethnic groups have varying
perceptions of the effects of the disorder on their QoL,
or they might be bothered to varying degrees by the
symptoms, but this study was not designed to obtain
data of this nature.
Conclusions
The ThyDQoL and ThySRQ are two new condition-
speciﬁc questionnaires measuring the perceived impact
of hypothyroidism on QoL, and bother ratings for 15
symptoms respectively, and allowing multidimensional
assessments of the effects of treatment for hypothy-
roidism. Both questionnaires are performing well with
good acceptability to the great majority of respon-
dents. The ThyDQoL has excellent internal consis-
tency reliability, domains can be analyzed separately if
required, and an overall score calculated. Additional
symptoms may be added to the ThySRQ to suit the
requirements of different studies. Sensitivity to change
of both measures now needs to be evaluated in clinical
trials.
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